bioAffinity Technologies receives Hong Kong patent for lung cancer test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to bioAffinity Technologies receives Hong Kong patent for lung cancer test

bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic

September 17, 2026 8:00 AM EDT

Dual patent protection in Hong Kong and China strengthens CyPath Lungs positioning to enter Asian market

Asia accounts for nearly two-thirds of lung cancer cases worldwide

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company developing noninvasive healthcare solutions... More